ArticlePloS one2017

Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model.

Alexander Y Deneka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.